Last reviewed · How we verify

ropivacaine, ketorolac and epinephrine

Region Örebro County · Phase 1 active Small molecule

ropivacaine, ketorolac and epinephrine is a Small molecule drug developed by Region Örebro County. It is currently in Phase 1 development.

At a glance

Generic nameropivacaine, ketorolac and epinephrine
SponsorRegion Örebro County
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ropivacaine, ketorolac and epinephrine

What is ropivacaine, ketorolac and epinephrine?

ropivacaine, ketorolac and epinephrine is a Small molecule drug developed by Region Örebro County.

Who makes ropivacaine, ketorolac and epinephrine?

ropivacaine, ketorolac and epinephrine is developed by Region Örebro County (see full Region Örebro County pipeline at /company/region-rebro-county).

What development phase is ropivacaine, ketorolac and epinephrine in?

ropivacaine, ketorolac and epinephrine is in Phase 1.

Related